尿道填充剂能否挽救吊带术后失败的压力性尿失禁?
本研究回顾性分析73例吊带术后失败的压力性尿失禁患者,接受尿道填充剂注射后71%报告短期症状改善,问卷评分显著提高,长期随访中压力性尿失禁和生活质量改善持续存在。
要点
- 吊带术后失败患者接受尿道填充剂注射,71%报告短期部分或完全缓解。
- 长期随访(平均39.6个月)压力性尿失禁和生活质量改善持续。
核心结论
- 吊带术后持续或复发性压力性尿失禁患者接受尿道填充剂注射后,71%获得短期改善或症状缓解。
- 在可获得数据的患者中,压力性尿失禁特异性改善平均持续35个月。
研究设计与样本
- 回顾性研究,纳入73例因吊带术后失败而接受尿道填充剂注射的患者。
主要发现
- 71%患者在首次注射后随访时报告至少部分症状缓解。
关键数值与推荐
- 短期改善率71%,平均注射次数2.6次。
- 长期随访平均39.6个月,压力性尿失禁改善平均持续35个月。
临床怎么用
- 对于吊带术后失败的压力性尿失禁患者,尿道填充剂注射可作为一种微创挽救治疗选择。
- 短期和长期随访中应关注症状改善及生活质量变化。
局限性
- 回顾性研究设计。
- 样本量有限(73例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of urethral bulking agents for stress urinary incontinence (SUI) in the setting of prior failed sling. METHODS: This is a retrospective review of patients who underwent urethral bulking agent injections for a primary complaint of SUI following prior failed sling surgery. The outcomes assessed were patient reported improvement, need for further interventions for incontinence and validated questionnaires. Values for questionnaires were obtained from the patient's preprocedure visit, at the first visit following their last injection and at their most recent visit within our system. RESULTS: Over the study period, 73 patients underwent urethral bulking agent injection following failed sling. Thirty-eight patients received Macroplastique injections and 35 had collagen injections. On average, patients underwent 2.6 injections. Seventy-one percent of patient reported at least partial symptom resolution at first postinjection follow-up. Validated questionnaire responses also improved at short-term follow-up (mean difference in American Urological Association Symptom Index-3.8, Michigan Incontinence Symptom Index-5.1, P <.01). Forty patients had long-term follow-up data available (mean 39.6 months postinjection). Statistically significant improvement persisted on the stress incontinence and quality of life domains of the validated questionnaires. CONCLUSION: In our cohort of patients with persistent or recurrent SUI following urethral sling procedure, 71% experienced short-term improvement or resolution of symptoms following urethral bulking agent injections, with SUI-specific improvement persisting at an average of 35 months in patients with available data.
引用
- Dray EV, Hall M, Covalschi D, et al. Can Urethral Bulking Agents Salvage Failed Slings? Urology. 2018. PMID: 30412703. doi:10.1016/j.urology.2018.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。